Institute

Consumer Perspectives on Quality of Healthcare Slides to All-Time Low

Retrieved on: 
Thursday, November 10, 2022
Perception, Doctor of Philosophy, Reuters, Plasma protein binding, Pulse, The Game Changers, Research, Institute, SRD, Ipsos, Solution, Movement, Time, SBF, FP, Patient, Social media, CEO, Health, Insurance, Euronext Paris, Trust, Pharmaceutical industry, Health insurance, Medicine, Twitter

NASHVILLE, Tenn., Nov. 10, 2022 /PRNewswire-PRWeb/ -- The Beryl Institute and Ipsos released findings from the tenth PX Pulse, a survey to track current perspectives on patient experience in healthcare across the United States. This report trends data related to the consumer experience from data first collected pre-pandemic in December 2019 through the third quarter of 2022. This issue reveals the challenges the healthcare industry faces as the world learns how to operationalize the realities of the pandemic. Specifically, the findings share consumers' perspective of quality of care and experience in healthcare today.

Key Points: 
  • Specifically, the findings share consumers' perspective of quality of care and experience in healthcare today.
  • Quality of healthcare hit its lowest percentage to date, with just 40% of respondents rating the quality of their healthcare as "Good" or "Very good," down 6 points from March of this year.
  • The Beryl Institute Ipsos PX Pulse represents a first-of-its-kind effort to elevate understanding of the current perspectives on patient experience in U.S. healthcare.
  • The Beryl Institute is a global community of healthcare professionals and experience champions committed to transforming the human experience in healthcare.

HER2DX® RECOGNIZED BY TIME AS ONE OF THE BEST INVENTIONS OF 2022

Retrieved on: 
Thursday, November 10, 2022
TIME, Research, Risk, University of Barcelona, Intention, HER2, Invention, Institute, Solution, Machine learning, CSO, Biomarker, Cancer, ERBB2, Biotechnology, University, Patient, Breast cancer, Social media, Woman, CEO, Recurrence, Antibiotics, Toy, Medicine, Medical imaging, Instagram, Facebook

HER2DX was highlighted in Times "Medical Care" category, which publicizes inventions that are successfully implemented in medical practice.

Key Points: 
  • HER2DX was highlighted in Times "Medical Care" category, which publicizes inventions that are successfully implemented in medical practice.
  • HER2DX is the first genomic test in the world specialized in HER2+ breast cancer and has been marketed by REVEAL GENOMICS since January 2022.
  • BARCELONA, Spain, Nov. 10, 2022 /PRNewswire/ -- REVEAL GENOMICS, S.L., a biotechnology start-up seeking to revolutionize precision oncology through biomarker innovation, has announced that HER2DX has been included as one of TIME's "Best Inventions of 2022 ".
  • HER2DX has been recognized as one of the top inventions in the "Medical Care" category, which highlights cutting-edge innovationsthat are successfully incorporated into clinical practice and provide patients with good outcomes.

Affluent consumers find value in agent expertise and will use an agent again, according to new Coldwell Banker Global Luxury data

Retrieved on: 
Thursday, November 10, 2022
NYSE, Real estate, School, Coldwell, Human, Environment, Trend, Institute, Coldwell Banker, Market Research Society, Research, ESOMAR, Ageing, Income, Public relations

MADISON, N.J., Nov. 10, 2022 /PRNewswire/ -- A recent survey released by Coldwell Banker Real Estate LLC, an AnywhereSM (NYSE: HOUS) brand, and the Coldwell Banker Global Luxury® program, indicates that buyers are looking for much more than a transactional relationship when it comes to choosing and staying with their agent. Real estate agents are now financial, wealth and lifestyle ambassadors, and consumers are finding more value in working with a real estate agent than ever before, especially as they face a transitioning market.

Key Points: 
  • The white glove service and world-class expertise of a top agent provides immeasurable value, as evidenced by the survey.
  • Four in five U.S. luxury consumers find value in using a luxury agent, says @ColdwellBanker survey.
  • The Coldwell Banker Global Luxury program legacy traces its roots to 1933 and has been a world leader in luxury real estate since.
  • Coldwell Banker, the Coldwell Banker logo Coldwell Banker Global Luxury and the Coldwell Banker Global Luxury logo are registered marks owned by Coldwell Banker Real Estate LLC.

Complete College America Names Kresge Foundation Program Officer to its Board of Directors

Retrieved on: 
Thursday, November 10, 2022
University of Pennsylvania, Graduate school, Color, CCA, The Kresge Foundation, Investment, Research, Organization, Center, Mary Lou Fulton Institute and Graduate School of Education, Multimedia, Institute, Pennsylvania State University, Policy, University of New Mexico, University, University of Southern California, Student, W. E. Upjohn Institute for Employment Research, Smith, Management, Education

INDIANAPOLIS, Nov. 10, 2022 /PRNewswire/ -- Complete College America, a national non-profit organization on a mission to raise postsecondary attainment in the United States, today announced the appointment of Dr. Edward Smith, a senior program officer with The Kresge Foundation's Education Program, to its board of directors.

Key Points: 
  • Nonprofit higher education reform network welcomes college access and success expert Dr. Edward Smith to its board of directors
    INDIANAPOLIS, Nov. 10, 2022 /PRNewswire/ -- Complete College America , a national non-profit organization on a mission to raise postsecondary attainment in the United States, today announced the appointment of Dr. Edward Smith , a senior program officer with The Kresge Foundation's Education Program, to its board of directors.
  • "Restoring the promise of higher education means that we must bring proven practices to institutions that have been for too long left behind by the college completion movement," said Dr. Yolanda Watson Spiva, president of Complete College America.
  • "Dr. Smith's deep experience in education policy research coupled with his expertise in higher education innovation, college opportunity and degree completion makes him an ideal fit to join our board.
  • I'm humbled and honored to have this opportunity to join Complete College America's board."

Financial Planning Association to Honor Influential Volunteer Leader with the Profession's Highest Award

Retrieved on: 
Thursday, November 10, 2022
Director, Education, Financial Planning Association of Australia, Honor, Finance, Leadership, Metro New York, Financial plan, FPA, Learning, Certified Financial Planner Board of Standards, College, Foundation, Organization, IAFP, Association, Parent, Certification, Board, Baruch College, Marymount College, Financial management, Institute, CFP, ICFP, Board of directors, NYU, Award, Government, Prime Minister's Awards for Teaching Excellence, MBA, Conference, Syracuse University, Heart, Growth, CEO, Financial adviser, Public relations, Management, New York University

DENVER, Nov. 10, 2022 /PRNewswire/ -- The Financial Planning Association® (FPA®), the leading membership organization and trade association for Certified Financial Planner™ professionals, is pleased to announce Scott M. Kahan, CFP®, as the recipient of the Association's and profession's highest individual award – the 2022 P. Kemp Fain, Jr., Award.

Key Points: 
  • "P. Kemp Fain was passionate about financial planning and devoted his career to laying a foundation for the future of the financial planning profession.
  • His years of impactful volunteer service locally and nationally in FPA and the Foundation for Financial Planning have strengthened the profession.
  • Kahan earned his CERTIFIED FINANCIAL PLANNER certification from the College for Financial Planning and a bachelor's degree from Syracuse University.
  • The Financial Planning Association (FPA) is the leading membership organization and trade association for Certified Financial Plannerprofessionals and those engaged in the financial planning process.

Icosavax to Participate in in Upcoming Investor Conferences

Retrieved on: 
Tuesday, November 8, 2022
GLOBE, Respiratory syncytial virus, Fireside, Vaccine, Severe acute respiratory syndrome coronavirus 2, Fireside chats, RSV, University of Washington Department of Global Health, Human, Technology, Investor relations, Institute, Infection, Virus, VLP, ET, University

The webcast replays will be available following the conclusion of the presentations for approximately 90 days.

Key Points: 
  • The webcast replays will be available following the conclusion of the presentations for approximately 90 days.
  • Icosavax is a biopharmaceutical company leveraging its innovative VLP platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases and a vision for combination and pan-respiratory vaccines.
  • Icosavax was formed in 2017 to advance the breakthrough VLP technology from the Institute for Protein Design at the University of Washington with the goal to discover, develop, and commercialize vaccines against infectious diseases.
  • Icosavax is located in Seattle.

National study suggests it’s time to rethink how we treat atrial fibrillation

Retrieved on: 
Tuesday, November 8, 2022
Quality of life, GLOBE, Catheter ablation, Leadership, Montreal Heart Institute, The New England Journal of Medicine, Atrial fibrillation, Research, Risk, Heart failure, Institute, Hospital, AF, HIV disease progression rates, Pharmacotherapy, Arrhythmia, Disease, MHI, Patient, Heart, American Heart Association, Recurrence, Stroke, Pharmaceutical industry, Medical device, Liquor, Medical imaging

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting approximately 1 to 2% of the overall population.

Key Points: 
  • Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting approximately 1 to 2% of the overall population.
  • Treatment guidelines recommend a trial of drug therapy to maintain a normal atrial heart rhythm before catheter ablation is considered.
  • This data provides clear evidence that an early invasive therapy may be a more effective method to improve the lives of our patients with atrial fibrillation.
  • The evidence shows increasingly that its time to rethink how we approach the treatment of atrial fibrillation.

DLR Selects Sopheon to Manage National Aerospace Agency’s Innovation Products and Systems

Retrieved on: 
Tuesday, November 8, 2022
GLOBE, Innovation management, Leadership, Alpha (finance), German Aerospace Center, Research, Technology, Institute, Federal republic, Accolade, Solution, London Stock Exchange, Software, London, SPE, DLR, Federation, CEO, Industry, LON, Renewable energy, Management, Acclaim, Sopheon

DLR has over 10,000 employees, working on projects ranging from fundamental to applied research to the development of the innovative products of tomorrow.

Key Points: 
  • DLR has over 10,000 employees, working on projects ranging from fundamental to applied research to the development of the innovative products of tomorrow.
  • Sopheon will help the Institute of Vehicle Concepts coordinate the many interdependencies that exist between products, systems, technologies and working groups.
  • Sopheons intuitive innovation roadmaps will be an essential guide for DLR to create technologies that produce a more sustainable future.
  • Accolade will enable DLR to identify and manage the interdependencies that research programs need to properly support innovation initiatives.

Trusted Health Community Names Its Most Trusted Award Winner

Retrieved on: 
Tuesday, November 8, 2022
GLOBE, Health, Marketing, Trust (social science), Mind share, Longevity, Institute, Third party (politics), Patient, MD, Trust, Public relations, Tutoring

The Trusted Authority award is bestowed on the health professional who grows an audience based on trust, respect, and credibility.They package their genius to attract their ideal clients and make the greatest impact on health outcomes.

Key Points: 
  • The Trusted Authority award is bestowed on the health professional who grows an audience based on trust, respect, and credibility.They package their genius to attract their ideal clients and make the greatest impact on health outcomes.
  • This year, the honor of Mindshare Collaborative's most Trusted Authority went to Tracy Gapin, MD, FACS.Dr.
  • It's considered the #1 source for health and wellness business strategies, tactics and community support.
  • For more information on what Mindshare is all about or to connect with one of its Trusted Authorities, please contact:

National study suggests it’s time to rethink how we treat atrial fibrillation

Retrieved on: 
Monday, November 7, 2022
Quality of life, GLOBE, Catheter ablation, Leadership, Montreal Heart Institute, The New England Journal of Medicine, Atrial fibrillation, Research, Risk, Heart failure, Institute, Hospital, AF, HIV disease progression rates, Pharmacotherapy, Arrhythmia, Disease, MHI, Patient, Heart, American Heart Association, Recurrence, Stroke, Pharmaceutical industry, Medical device, Liquor, Medical imaging

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting approximately 1 to 2% of the overall population.

Key Points: 
  • Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting approximately 1 to 2% of the overall population.
  • Treatment guidelines recommend a trial of drug therapy to maintain a normal atrial heart rhythm before catheter ablation is considered.
  • This data provides clear evidence that an early invasive therapy may be a more effective method to improve the lives of our patients with atrial fibrillation.
  • The evidence shows increasingly that its time to rethink how we approach the treatment of atrial fibrillation.